Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

MICAFUNGIN IN SODIUM CHLORIDE 0.9%

MICAFUNGIN SODIUM

Standard Dose
EQ 100MG BASE/100ML (EQ 1MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MICAFUNGIN IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 216142 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MICAFUNGIN SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2023-09-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview MICAFUNGIN IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 216142 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MICAFUNGIN SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2023-09-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MICAFUNGIN IN SODIUM CHLORIDE 0.9% (MICAFUNGIN SODIUM) | Drug Monograph | MedicHelpline